RE:RE:RE:Seeking alphaKuato,Good observation, you are usually dead on.. and its hard to fathom we are worth half of what we where worth last year as,(Pozn) and all the possitives we have now had in a row,(Yosprala, New $, new drug portfolio,etc, etc..)sort of makes you think. Imagine if we had any bad news?
I know Adams is a great tactician, and the last drug purchase was a "gimme" and fantastic pickup. With a fresh new sales force in order, I would almost bet money old sales perk up and we profit quickly. Just more ammo in earning capacity.
The problem I see, and its a big problem, Is if, on any future coming quarter (s) we get great earning and subsequentially.. tied in with good news.. we are met with millions of shares on the sell side, there may be some hell to pay.
I dont want to speculate, Options, shorts sellers, Insiders, etc..
We are not there yet and I want to be really optimistic, but so far I am seeing a stock trade lower then it should be.. and we might be writing letter's to FINRA and NASDAQ somewhere in 2017..
Just my 2 cents..